Published: March 09, 2006
Chelsea Management Group's Recently Introduced Exomine and Exomine RH Now Available Online
DENVER, March 9, 2006 (PRIMEZONE) -- Chelsea Management Group Inc. is pleased to announce today its recently introduced products, Exomine and Exomine RH, have been added to the website www.wellnessbegins.com.
The website has recently been updated to be more informative and user friendly, making our products easily accessible to our new and existing customers.
Exomine and Exomine RH are natural products developed to reduce pain caused by arthritis. Exomine is formulated to reduce joint pain and reduce pain caused by Osteoarthritis. In one study, subjects who took the same ingredients that are in Exomine experienced a gradual reduction in joint pain and tenderness while improving flexibility.
Exomine RH is a unique blend of ingredients specifically formulated to support those suffering from Rheumatoid Arthritis. While rheumatoid arthritis usually affects the mid-aged population, RA can often occur in your twenties and thirties.
Chelsea Management Group will endeavor to expand their product lines as they become available. Please visit the website www.wellnessbegins.com for more information or to order Exomine, Exomine RH and other products.
About Chelsea Management Group Inc.
Chelsea Management Group is a start-up and early-stage venture capital firm focused on the health and life sciences industry. Formed in 2001, Chelsea searches for the winners of tomorrow -- entrepreneurs whose ideas and talents qualify them to pursue large market opportunities successfully. We seek opportunities across a broad spectrum, including biotechnology and pharmaceuticals, medical devices, services and healthcare/life sciences information technology. On a selective basis, we also consider later-stage health and life sciences investments where we can uniquely apply Chelsea's industry and capital markets experience.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e. future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control and may yield results differing materially from those anticipated.
CONTACT: Chelsea Management Group Inc.
Investor Relations
John Viccar, Director
(303) 657-2764
Search News
